Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
Triple negative breast cancers (TNBCs) do not respond to conventional estrogen receptor/progesterone receptor/human epidermal growth factor receptor-2 targeted interventions due to the absence of the respective receptor targets. They are aggressive, exhibit early recurrence, metastasize, are more in...
Main Authors: | Elizabeth Varghese, Samson Mathews Samuel, Sharon Varghese, Sohaila Cheema, Ravinder Mamtani, Dietrich Büsselberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/8/4/163 |
Similar Items
-
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
by: Elizabeth Varghese, et al.
Published: (2018-09-01) -
Triptolide Resistance Was Prevented by Metformin Co-Treatment Under Increased Growth Hormone Signaling Conditions in MDA-MB-231 Cells
by: Gizat Rakhmatula, et al.
Published: (2019-12-01) -
Autocrine Growth Hormone (GH)-Mediated Triptolide Resistance Overcame by Metformin Co-Treatment in MDA-MB231 Breast Cancer Cells Through ER Stress Pathway
by: Amani Abdulmunem, et al.
Published: (2019-12-01) -
Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin
by: Zhiwei Zhang, et al.
Published: (2019-01-01) -
Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231
by: Ahmat, N, et al.
Published: (2019)